FDA approved Pfizer-BioNTech’s XFG-adapted COMIRNATY formula for adults 65 and older and high-risk people aged 5 to 64 years.
|Articles|April 26, 2021
COVID-19 Updates: US Vaccinations and Global Cases and Deaths as of April 26, 2021
Author(s)Sydney Jennings
US confirmed cases of COVID-19 have surpassed 32 million. Plus more data from the Johns Hopkins COVID-19 interactive map and the CDC on COVID-19 cases, mortalities, vaccinations, and more.
Advertisement
How many people in the US have been vaccinated against COVID-19?
According to the US
• 42.5% of total US population have received at least 1 dose
• 28.9% of total US population are fully vaccinated
• 28.9% of total US population are fully vaccinated
The 5 states with the highest percentage of population fully vaccinated are:
1. Connecticut: 36.4%
2. Maine: 36.3%
3. New Mexico: 35.7%
4. Vermont: 35.6%
5. South Dakota: 34.9%
2. Maine: 36.3%
3. New Mexico: 35.7%
4. Vermont: 35.6%
5. South Dakota: 34.9%
How many cases of COVID-19 have been confirmed in the US?
According to the
• 32 088 686 confirmed cases
• 572 272 deaths
• 572 272 deaths
The 5 states with the highest total confirmed cases are:
1. California: 3 731 772
2. Texas: 2 874 087
3. Florida: 2 208 584
4. New York: 2 031 093
5. Illinois: 1 320 934
2. Texas: 2 874 087
3. Florida: 2 208 584
4. New York: 2 031 093
5. Illinois: 1 320 934
Deaths: California has the most deaths due to COVID-19 with 61 479 reported fatalities, followed by New York with 52 003, and Texas with 49 936.
How many cases of COVID-19 have been confirmed globally?
Globally, there have been 147 325 436 confirmed cases, 3 112 206 deaths, and 85 028 957 recoveries.
Advertisement
Related to this article
A Vaccine Integrity Project review found influenza, COVID-19, and RSV immunizations continue to protect against severe illness, hospitalization, and death.
Pre-existing antibodies to common microbes predicted COVID-19 vaccine response strength in healthy and immunosuppressed adults.
FDA approved bictegravir/lenacapavir for adults with suppressed HIV-1 and no known or suspected component resistance.
FDA expands dolutegravir dispersible tablets to children with HIV-1 weighing at least 2 kg, including eligible term newborns.
The organizations challenge a presidential executive order narrowing routine childhood vaccine recommendations and urging vaccines to be given separately.
FDA updates sotatercept-csrk label with HYPERION data, showing earlier use cuts PAH clinical worsening risk 76% alongside background therapy.
A US laboratory study found that 29.5% of patients with Lyme antibodies were seropositive for at least 1 other tick-borne pathogen.
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves Sotatercept-csrk Label Update for Newly Diagnosed PAH
2
Lumateperone Reduces Acute Mania Symptoms in Phase 3 Bipolar I Trial
3
Endocrine Society Obesity Statement Calls for Goals Beyond Weight Loss
4
Clinical Inertia and Poor Measurement Technique Undermine BP Control
5